T
T. Allen Merritt
Researcher at Loma Linda University
Publications - 84
Citations - 3868
T. Allen Merritt is an academic researcher from Loma Linda University. The author has contributed to research in topics: Respiratory distress & Pulmonary surfactant. The author has an hindex of 32, co-authored 83 publications receiving 3689 citations. Previous affiliations of T. Allen Merritt include Carolinas Medical Center & Scripps Health.
Papers
More filters
Journal ArticleDOI
Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial.
Mikko Hallman,T. Allen Merritt,Anna-Liisa Järvenpää,Bruce R. Boynton,Frank L. Mannino,Louis Gluck,Thomas R. Moore,David Edwards +7 more
TL;DR: The efficacy of treatment with human surfactant in preterm infants with severe respiratory distress syndrome is confirmed and pneumothorax, pulmonary interstitial emphysema, and need for FiO2 greater than or equal to 0.3 for greater than 30 days was significantly less in the surfactan group.
Journal ArticleDOI
Prophylactic Treatment of Very Premature Infants with Human Surfactant
T. Allen Merritt,T. Allen Merritt,Mikko Hallman,Mikko Hallman,Barry T. Bloom,Barry T. Bloom,Charles C. Berry,Charles C. Berry,Kurt Benirschke,Kurt Benirschke,David J Sahn,Thomas C. Key,Thomas C. Key,David K. Edwards,David K. Edwards,Anna Liisa Jarvenpaa,Anna Liisa Jarvenpaa,Maija Pohjavuori,Maija Pohjavuori,Kaisa Kankaanpaa,Kaisa Kankaanpaa,Marjatta Kunnas,Marjatta Kunnas,Heikki Paatero,Heikki Paatero,Juhani Rapola,Juhani Rapola,Jaakko Jaaskelainen,Jaakko Jaaskelainen +28 more
TL;DR: It is concluded that treatment with human surfactant offers promise for improving the survival of very premature infants with a Surfactant deficiency and for reducing the pulmonary sequelae of the respiratory distress syndrome.
Journal ArticleDOI
Glutaric aciduria Type II
TL;DR: Organic acid analysis revealed massive lactic aciduria and glutaric aciduria, and the pattern of metabolites accumulated is consistent with deficient activity of a number of acyl-CoA dehydrogenases.
Journal ArticleDOI
A multicenter, randomized, controlled trial comparing Surfaxin (Lucinactant) lavage with standard care for treatment of meconium aspiration syndrome.
Thomas E. Wiswell,Gail Knight,Neil N. Finer,Steven M. Donn,Hemant Desai,William F. Walsh,Krishnamurthy Sekar,Graham Bernstein,Graham Bernstein,Martin Keszler,Martin Keszler,Valya E. Visser,Valya E. Visser,Valya E. Visser,T. Allen Merritt,T. Allen Merritt,Frank L. Mannino,Lisa Mastrioianni,Lisa Mastrioianni,Brian Marcy,Brian Marcy,Susan D. Revak,Huei Tsai,Huei Tsai,Charles G. Cochrane +24 more
TL;DR: Dilute Surfaxin lavage seems to be a safe and potentially effective therapy in the treatment of MAS, and data from this investigation support future prospective, controlled clinical trials of bronchoalveolar lavage withSurfaxin in neonates with MAS.
Journal ArticleDOI
The contribution of PDA in the neonate with severe RDS
Richard E. Behman,Jack Jacob,Jack Jacob,Louis Gluck,Louis Gluck,Thomas G. Disessa,Thomas G. Disessa,David K. Edwards,David K. Edwards,Marie V. Kulovich,Marie V. Kulovich,John Kurlinski,John Kurlinski,T. Allen Merritt,T. Allen Merritt,William F. Friedman,William F. Friedman +16 more
TL;DR: The data suggest that severe RDS presents as a developmental spectrum and provides the justification for a controlled trial of very early closure of the PDA in the very low-birth-weight infant with severe R DS.